These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9949259)

  • 21. Editorial: anti-secretory therapy prior to anti-reflux surgery. Does dose matter?
    Schnoll-Sussman F; Katz PO
    Aliment Pharmacol Ther; 2015 Sep; 42(5):626. PubMed ID: 26238577
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapeutic approaches to reflux disease, focusing on acid secretion.
    Kinoshita Y; Adachi K; Fujishiro H
    J Gastroenterol; 2003 Mar; 38 Suppl 15():13-9. PubMed ID: 12698865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care.
    Martin RM; Lim AG; Kerry SM; Hilton SR
    Aliment Pharmacol Ther; 1998 Aug; 12(8):797-805. PubMed ID: 9726394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease.
    Ruigómez A; Hungin AP; Lundborg P; Johansson S; Wallander MA; García Rodríguez LA
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):232-7. PubMed ID: 21258240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing chronic gastroesophageal reflux disease.
    Seehusen DA; Escano J
    Am Fam Physician; 2012 Oct; 86(7):617-9. PubMed ID: 23062089
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapy for gastroesophageal reflux disease: more is not necessarily better.
    Metz DC
    Am J Gastroenterol; 2003 Sep; 98(9):1913-5. PubMed ID: 14499765
    [No Abstract]   [Full Text] [Related]  

  • 27. Editorial: anti-secretory therapy prior to anti-reflux surgery. Does dose matter? Authors' reply.
    Lødrup A; Pottegård A; Hallas J; Bytzer P
    Aliment Pharmacol Ther; 2015 Sep; 42(5):627. PubMed ID: 26238578
    [No Abstract]   [Full Text] [Related]  

  • 28. Fixed combination of hyaluronic acid and chondroitin-sulphate oral formulation in a randomized double blind, placebo controlled study for the treatment of symptoms in patients with non-erosive gastroesophageal reflux.
    Palmieri B; Merighi A; Corbascio D; Rottigni V; Fistetto G; Esposito A
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3272-8. PubMed ID: 24379055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gastroesophageal reflux: current status of therapy].
    Seifert E
    Leber Magen Darm; 1995 Jul; 25(4):156-60, 163. PubMed ID: 7564869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acid suppression therapy: where do we go from here?
    Scarpignato C; Pelosini I; Di Mario F
    Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor.
    Juul-Hansen P; Rydning A
    Aliment Pharmacol Ther; 2009 Jan; 29(2):207-12. PubMed ID: 19006541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acid pump inhibitors. The treatment of gastroesophageal reflux.
    Hetzel D
    Aust Fam Physician; 1998 Jun; 27(6):487-91. PubMed ID: 9648315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastroesophageal reflux disease: pathophysiology and pharmacology overview.
    Dajani EZ
    J Assoc Acad Minor Phys; 2000; 11(1):7-11. PubMed ID: 10826019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of H2-receptor antagonist and proton pomp inhibitor on the treatment of acid-related disease].
    Kawai T; Yagi K; Moriyasu F
    Nihon Rinsho; 2015 Jul; 73(7):1159-62. PubMed ID: 26165073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of gastroesophageal reflux disease.
    Pettit M
    Pharm World Sci; 2005 Dec; 27(6):432-5. PubMed ID: 16341949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antireflux surgery.
    Gatenby PA; Bann SD
    Minerva Chir; 2009 Apr; 64(2):169-81. PubMed ID: 19365317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitor failure--what are the therapeutic options?
    Fass R
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S33-8. PubMed ID: 19262545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rebound acid hypersecretion.
    McColl KE
    Basic Clin Pharmacol Toxicol; 2004 May; 94(5):201. PubMed ID: 15125688
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term management of gastroesophageal reflux disease and its complications.
    Richter JE
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.